234 related articles for article (PubMed ID: 25835498)
1. Association between P16INK4a promoter methylation and HNSCC: a meta-analysis of 21 published studies.
Shi H; Chen X; Lu C; Gu C; Jiang H; Meng R; Niu X; Huang Y; Lu M
PLoS One; 2015; 10(4):e0122302. PubMed ID: 25835498
[TBL] [Abstract][Full Text] [Related]
2. Association between P16INK4a Promoter Methylation and Ovarian Cancer: A Meta-Analysis of 12 Published Studies.
Xiao X; Cai F; Niu X; Shi H; Zhong Y
PLoS One; 2016; 11(9):e0163257. PubMed ID: 27648827
[TBL] [Abstract][Full Text] [Related]
3. Aberrant Methylation of RASSF1A Closely Associated with HNSCC, a Meta-Analysis.
Meng RW; Li YC; Chen X; Huang YX; Shi H; Du DD; Niu X; Lu C; Lu MX
Sci Rep; 2016 Feb; 6():20756. PubMed ID: 26857374
[TBL] [Abstract][Full Text] [Related]
4. Association between promoter methylation of DAPK gene and HNSCC: A meta-analysis.
Cai F; Xiao X; Niu X; Zhong Y
PLoS One; 2017; 12(3):e0173194. PubMed ID: 28249042
[TBL] [Abstract][Full Text] [Related]
5. The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: a Meta-Analysis.
Zhou C; Shen Z; Ye D; Li Q; Deng H; Liu H; Li J
Cell Physiol Biochem; 2018; 50(3):868-882. PubMed ID: 30355925
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P
Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769
[TBL] [Abstract][Full Text] [Related]
8. Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma.
Steinmann K; Sandner A; Schagdarsurengin U; Dammann RH
Oncol Rep; 2009 Dec; 22(6):1519-26. PubMed ID: 19885608
[TBL] [Abstract][Full Text] [Related]
9. [Association of the expression of p53 and p16INK4A with the clinical and morphological characteristicsof patients with head and neck squamous cell cancer].
Stukan AI; Chukhray OY; Porkhanov VA; Bodnya VN
Arkh Patol; 2019; 81(3):12-18. PubMed ID: 31317926
[TBL] [Abstract][Full Text] [Related]
10. FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.
Teh MT; Gemenetzidis E; Patel D; Tariq R; Nadir A; Bahta AW; Waseem A; Hutchison IL
PLoS One; 2012; 7(3):e34329. PubMed ID: 22461910
[TBL] [Abstract][Full Text] [Related]
11. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
[TBL] [Abstract][Full Text] [Related]
12. Dietary folate is associated with p16(INK4A) methylation in head and neck squamous cell carcinoma.
Kraunz KS; Hsiung D; McClean MD; Liu M; Osanyingbemi J; Nelson HH; Kelsey KT
Int J Cancer; 2006 Oct; 119(7):1553-7. PubMed ID: 16646054
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
14. A systematic review and meta-analysis approach on diagnostic value of MLH1 promoter methylation for head and neck squamous cell carcinoma.
Li Q; Hong J; Shen Z; Deng H; Shen Y; Wu Z; Zhou C
Medicine (Baltimore); 2019 Oct; 98(43):e17651. PubMed ID: 31651887
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation and loss of p16(INK4a) gene expression in head and neck cancer.
Demokan S; Chuang A; Suoğlu Y; Ulusan M; Yalnız Z; Califano JA; Dalay N
Head Neck; 2012 Oct; 34(10):1470-5. PubMed ID: 22106032
[TBL] [Abstract][Full Text] [Related]
17. Bronchial lavage P 16INK4A gene promoter methylation and lung cancer diagnosis: A meta-analysis.
Yifan D; Qun L; Yingshuang H; Xulin L; Jianjun W; Qian M; Yuman Y; Zhaoyang R
Indian J Cancer; 2015 Dec; 52 Suppl 2():e96-8. PubMed ID: 26728683
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
Misawa Y; Misawa K; Kanazawa T; Uehara T; Endo S; Mochizuki D; Yamatodani T; Carey TE; Mineta H
Cancer; 2014 Jan; 120(2):205-13. PubMed ID: 24122450
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Methylation of MGMT Promoter in HNSCC: A Meta-Analysis.
Cai F; Xiao X; Niu X; Shi H; Zhong Y
PLoS One; 2016; 11(9):e0163534. PubMed ID: 27657735
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16INK4a.
Waber P; Dlugosz S; Cheng QC; Truelson J; Nisen PD
Oncogene; 1997 Oct; 15(14):1699-704. PubMed ID: 9349503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
